Medicare Part D may necessitate opioid switches

Crespi-Lofton, Judy
December 2005
Pharmacy Today;Dec2005, Vol. 11 Issue 12, p14
The article presents information on the benefits of a Medicare prescription drug plan known as Medicare Part D. Through this plan, millions of Medicare beneficiaries will begin receiving prescription drug benefits. These plans are permitted to use formularies along with step therapy and prior authorization. From plan to plan, formulary requirements will differ. In order to have their prescriptions covered by their plan, many patients will need to switch analgesic medications. With the commencement of this plan, beneficiaries will need to obtain medications that are therapeutically equivalent to those they are already taking.


Related Articles

  • The impact of the Medicare Part D prescription benefit on generic drug use. Zhang, James X.; Yin, Wesley; Sun, Shawn X.; Alexander, G. Caleb // JGIM: Journal of General Internal Medicine;Oct2008, Vol. 23 Issue 10, p1673 

    Background: Little information exists regarding the impact of Medicare Part D on generic drug use.Objective: To examine changes in the use of generic prescriptions attributable to Part D among a sample of Medicare beneficiaries.Design, Participants, and...

  • Non-prescription medicines: prescribing legislation. Nathan, Alan // Nursing Standard;9/7/2005, Vol. 19 Issue 52, p41 

    This article discusses developments in prescribing legislation in relation to non-prescription medicines. The three supply categories are outlined: prescription only, general sale list, and pharmacy medicines. Changes in legislation towards increased availability of medicines that do not require...

  • Adverse Selection? A Multi-Dimensional Profile of People Dispensed Opioid Analgesics for Persistent Non-Cancer Pain. Rogers, Kris D.; Kemp, Anna; McLachlan, Andrew J.; Blyth, Fiona // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Objectives: This study investigates utilisation patterns for prescription opioid analgesics in the Australian community and how these are associated with a framework of individual-level factors related to healthcare use. Methods: Self-reported demographic and health information from participants...

  • Opposite Drug Prescription and Cost Trajectories following Integrative and Conventional Care for Pain – A Case-Control Study. Sundberg, Tobias; Petzold, Max; Kohls, Niko; Falkenberg, Torkel // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Objectives: Pharmacotherapy may have a limited role in long-term pain management. Comparative trajectories of drug prescriptions and costs, two quality-of-care indicators for pain conditions, are largely unknown subsequent to conventional or integrative care (IC) management. The objectives of...

  • Variations in GP prescribing of CHD drugs criticised as 'unjustifiable' Kelly, Brian // Pulse;1/26/2004, Vol. 64 Issue 4, p14 

    Reports on the study led by Peter Ward at Sheffield Hallam University in Sheffield, England which concludes that there are unjustifiable variations in general practitioners' prescribing of coronary heart disease drugs. Details of the research; Publications of the findings in the February 2003...

  • Independent and supplementary prescribing and PGDs. Baird, Anne // Nursing Standard;8/31/2005, Vol. 19 Issue 51, p51 

    Types of prescribing for non-medical staff are discussed and clarifications made regarding the current overlap in six forms of prescribing and administration of medication. Differences between independent and supplementary prescribing are explored and the distinction between patient group...

  • How to Read Your Prescription.  // Monkeyshines on Health & Science;Mar2002 Events In Medicine, p43 

    Offers tips on how to read prescriptions.

  • Dispensing of Electronically Discontinued Medications. James A. Villier; Allen, Adrienne S. // Annals of Internal Medicine;4/2/2013, Vol. 158 Issue 7, p671 

    A letter to the editor and a response from the authors of the article "Pharmacy Dispensing of Electronically Discontinued Medications" in the 2012 issue are presented.

  • Opioid Prescribing Behaviors -- Prescription Behavior Surveillance System, 11 States, 2010-2016. Strickler, Gail K.; Kreiner, Peter W.; Halpin, John F.; Doyle, Erin; Paulozzi, Leonard J. // MMWR Surveillance Summaries;1/31/2020, Vol. 69 Issue 1, p1 

    Problem/Condition: In 2017, a total of 70,237 persons in the United States died from a drug overdose, and 67.8% of these deaths involved an opioid. Historically, the opioid overdose epidemic in the United States has been closely associated with a parallel increase in opioid prescribing and with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics